Related Experiment Video
Updated: Feb 7, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Real-Time Named Entity Recognition from Textual Electronic Clinical Records in Cancer Therapy Using Low-Latency
Pir Noman Ahmad1, Muhammad Shahid Anwar1, Saleha Masood1
1IRC for Finance and Digital Economy, KFUPM Business School, King Fahd University of Petroleum and Minerals College of Sciences, Dhahran, Saudi Arabia.
Abstract:
Named entity recognition (NER) is a core task in natural language processing that identifies and classifies entities, such as people, organizations, and locations within text. It has traditionally been applied in areas like text summarization, machine translation, and question answering. In recent years, NER has gained growing importance in health care, where electronic clinical records and online platforms generate large amounts of unstructured medical data. However, applying NER in clinical contexts introduces unique challenges due to the complexity of medical terminology and the need for high accuracy. In this study, we focused on the development of a real-time, low-latency NER system designed for cross-lingual speech-to-text applications, with a particular emphasis on cancer therapy-related clinical records and traditional Chinese medicine (TCM). We explored the integration of deep learning (DL) architectures optimized for low-latency neural processing to extract structured information from multilingual spoken content in medical settings, particularly in multimodal environments. We evaluate DL-based methods and propose a semi-supervised approach that combines TCM-specific corpora with biomedical resources to improve recognition accuracy. The findings provide both a systematic review of current methods and practical insights for building real-time clinical applications that support decision-making and information management in health care.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Naming Enantiomers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Real Time RT-PCR
The real-time quantification of the number of amplified products is...
Naming Skeletal Muscles
The key factors used in naming muscles include:
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...

